Equity Analysis /
United States of America

US : Antares Pharma, Inc. - ATRS | Weekly Rx Metrics: Back-to-School Boosts EpiPen Trends; XYOSTED Etches New High

    Michael Parolari
    Michael Parolari

    Research Associate

    CGS-CIMB
    30 August 2021
    Published by